Doron Birger
Chairman of the Board
Claimed by owner Matricelf
Former names: My Cell Therapeutics
Personalized Platform for Autologous Regenerative Medicine
Public on TASE Jun, 2021
Matricelf
www.themarker.com
•
Jan 18, 2023
מטריסלף נוסקת ב-23% בעקבות הצלחה בייצור שתל רקמה עצבית אנושית
en.globes.co.il
•
Oct 3, 2022
Israeli biotech co Matricelf ranked 3rd in Startups World Cup
www.prnewswire.com
•
May 2, 2022
Matricelf has reached a major milestone
en.globes.co.il
•
Jan 30, 2022
Matricelf teams with TAU on 3D organ printing
en.globes.co.il
•
Jan 11, 2022
Matricelf treats pig's spinal cord injury with human implants
www.sponser.co.il
•
Oct 25, 2021
חברת המו"פ מטריסלף מקבלת אישור להתקדמות פיתוח המוצר המרכזי
www.sponser.co.il
•
Jul 28, 2021
מטריסלף השלימה בהצלחה ניסוי לייצור שתל נוירונלי אנושי
www.funder.co.il
•
Jun 16, 2021
חברת הביוטכנולוגיה מטריסלף מצטרפת לבורסה בתל-אביב
www.globes.co.il
•
May 3, 2021
חברה העוסקת בפיתוח איברים מלאכותיים מבקשת להנפיק בת"א
www.calcalistech.com
•
Jan 13, 2021
Matricelf, the maker of 3D printed heart, named regional winner of the Startup World Cup
www.calcalistech.com
•
Dec 30, 2020
Israeli biotech company Matricelf wins Calcalist's StartUp+ competition
www.calcalist.co.il
•
Dec 30, 2020
המנצחת בתחרות +StartUp: חברת הביוטכנולוגיה מטריסלף
www.israel21c.org
•
Jul 5, 2020
Bayer, Tel Aviv University test drugs on 3D-printed hearts
www.businesswire.com
•
Nov 19, 2019
SEED AWARD Moves Matricelf One Step Closer to Creating World's First 3D Printed Human Heart
www.timesofisrael.com
•
Apr 15, 2019
Israeli scientists unveil world's first 3D-printed heart with human tissue
About
Matricelf has developed a technology that enables the production of autologous engineered tissue composed of matrix and cells derived from patients omental biopsies. In 2019, Matricelf licensed the technology that enabled scientists at Tel Aviv university to 3D print a human heart from human cells and matrix for the first time in history.
Matricelfs proprietary decellularization process separates stromal cells and extracellular matrix (ECM) from a small omental biopsy sample. A thermo-responsive hydrogel is produced from the ECM, and the stromal cells are reprogrammed into induced pluripotent stem cells (iPSCs) which are then incorporated into the hydrogel before being differentiated into the desired functional tissue using Matricelfs patent-pending methodology.
When combined with motor neurons, Matricelfs proprietary hydrogel creates functional spinal cord implants that can bridge injured spinal cord tissue. The companys novel regenerative medicine platform aims to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinsons disease, myocardial infarction, and others.
Following successful preclinical results, the first human clinical trial is scheduled for 2023.
Matricelfs proprietary decellularization process separates stromal cells and extracellular matrix (ECM) from a small omental biopsy sample. A thermo-responsive hydrogel is produced from the ECM, and the stromal cells are reprogrammed into induced pluripotent stem cells (iPSCs) which are then incorporated into the hydrogel before being differentiated into the desired functional tissue using Matricelfs patent-pending methodology.
When combined with motor neurons, Matricelfs proprietary hydrogel creates functional spinal cord implants that can bridge injured spinal cord tissue. The companys novel regenerative medicine platform aims to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinsons disease, myocardial infarction, and others.
Following successful preclinical results, the first human clinical trial is scheduled for 2023.
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
-
Funding
Total Funding
$10.04M
Market Cap
$26.43M
Last Funding
$7.4M
Funding Stage
Total Rounds
5
Investors
2
News
(15)
www.themarker.com
•
Jan 18, 2023
מטריסלף נוסקת ב-23% בעקבות הצלחה בייצור שתל רקמה עצבית אנושית
en.globes.co.il
•
Oct 3, 2022
Israeli biotech co Matricelf ranked 3rd in Startups World Cup
www.prnewswire.com
•
May 2, 2022
Matricelf has reached a major milestone
en.globes.co.il
•
Jan 30, 2022
Matricelf teams with TAU on 3D organ printing
en.globes.co.il
•
Jan 11, 2022
Matricelf treats pig's spinal cord injury with human implants
www.sponser.co.il
•
Oct 25, 2021
חברת המו"פ מטריסלף מקבלת אישור להתקדמות פיתוח המוצר המרכזי
www.sponser.co.il
•
Jul 28, 2021
מטריסלף השלימה בהצלחה ניסוי לייצור שתל נוירונלי אנושי
www.funder.co.il
•
Jun 16, 2021
חברת הביוטכנולוגיה מטריסלף מצטרפת לבורסה בתל-אביב
www.globes.co.il
•
May 3, 2021
חברה העוסקת בפיתוח איברים מלאכותיים מבקשת להנפיק בת"א
www.calcalistech.com
•
Jan 13, 2021
Matricelf, the maker of 3D printed heart, named regional winner of the Startup World Cup
www.calcalistech.com
•
Dec 30, 2020
Israeli biotech company Matricelf wins Calcalist's StartUp+ competition
www.calcalist.co.il
•
Dec 30, 2020
המנצחת בתחרות +StartUp: חברת הביוטכנולוגיה מטריסלף
www.israel21c.org
•
Jul 5, 2020
Bayer, Tel Aviv University test drugs on 3D-printed hearts
www.businesswire.com
•
Nov 19, 2019
SEED AWARD Moves Matricelf One Step Closer to Creating World's First 3D Printed Human Heart
www.timesofisrael.com
•
Apr 15, 2019
Israeli scientists unveil world's first 3D-printed heart with human tissue
The Team
(4)
DB
Asaf Toker
CEO
AS
Alon Sinai
Co-founder & COO
TH
Tamar Harel-Adar
VP R&D
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Public Offerings & Exits
Initial Public Offering
EXIT
$7.4M
Jun 2021
Stock Exchange
TASE
Valuation
$22M
$7.4M
Private Equity Funding
Seed
$1M
May 2020
1 Investors
$1M
Undisclosed Round
Undisclosed
Sep 2020
1 Investors
Undisclosed
Undisclosed Round
$1.5M
Nov 2020
1 Investors
$1.5M
Non-Equity Funding
Grant
$143K
Nov 2019
1 Grantors
$143K
Others
Academic Techonology
Apr 2019
undefined
A Facile and Safe, Suture-Free Technology, for the Attachment of Engineered Tissues to Organs
Media gallery
(2)
Matricelf
SEED AWARD 2019 Final - Matricelf
Locations
Israel
פארק המדע, גולדה מאיר 3, נס ציונה, Israel
Locations
Israel
פארק המדע, גולדה מאיר 3, נס ציונה, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,